Sign in Subscribe
Genetic research

Acute Lymphoblastic Leukemia: New Research Reveals Distinct Genetic Profiles and Favorable Outcomes in Infants and Toddlers

Strategic Insights

— 1 min read

New research conducted at the Necker Hospital for Sick Children (INEM) Institute has shed light on the genetic characteristics of acute lymphoblastic leukemia (ALL) in infants and toddlers. The study, which was published in the journal HemaSphere, analyzed the genetic profiles of 27 infant and toddler ALL cases and found that these young patients exhibited distinct clinical and genetic profiles compared to their older counterparts. The researchers identified a significant prevalence of NKX2 rearrangements, co-occurring with MYB alterations or chromothripsis-like events, as well as TAL1/-like anomalies, STAG2::LMO2, and ETS rearrangements. Notably, the study found that patients with alterations in NKX2, KMT2A, and STAG2::LMO2 showed a remarkable 100% overall survival rate.

Key Takeaways:

  • The study analyzed 27 infant and toddler ALL cases from a French national cohort and found distinct clinical and genetic profiles compared to older pediatric patients.
  • The researchers identified a significant prevalence of NKX2 rearrangements (33%), co-occurring with MYB alterations or chromothripsis-like events, in infant and toddler ALL patients.
  • Patients with alterations in NKX2, KMT2A, and STAG2::LMO2 showed a remarkable 100% overall survival rate.
  • The study found that infant and toddler ALL patients presented with higher rates of hyperleukocytosis and slower responses to treatment compared to older pediatric patients.
  • The researchers concluded that large-scale collaborative studies are essential to confirm these findings and refine treatment strategies for infant and toddler ALL.

Statistics:

  • 27 infant and toddler ALL cases were analyzed in the study.
  • The study reported a 33% prevalence of NKX2 rearrangements in infant and toddler ALL patients.
  • Patients with alterations in NKX2, KMT2A, and STAG2::LMO2 showed a 100% overall survival rate.
  • The overall survival rate for infant and toddler ALL patients was 75.4% (95% CI: 60.0%-94.8%).
  • The study found that infant and toddler ALL patients presented with higher rates of hyperleukocytosis compared to older pediatric patients.

Sources:

  • Oncogenomic profiling in infant-toddler T-ALL identifies NKX2 family genes as drivers linked to favorable outcomes. HemaSphere, 2025, 9(5):n/a-n/a. (HemaSphere - http://www.hemaspherejournal.com)
  • NewsRx. Research from Necker Hospital for Sick Children (INEM) Institute Has Provided New Study Findings on Acute Lymphoblastic Leukemia (Oncogenomic profiling in infant-toddler T-ALL identifies NKX2 family genes as drivers linked to favorable outcomes). Hematology Week. June 16, 2025; p 3984.

Read more